Alessandra Falchi Selected Research

Vaccines

3/2024	COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022.
1/2023	Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021-2022 I-MOVE primary care multicentre study.
1/2022	Seroprevalence of SARS-CoV-2 IgG Antibodies and Factors Associated with SARS-CoV-2 IgG Neutralizing Activity among Primary Health Care Workers 6 Months after Vaccination Rollout in France.
1/2021	Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021.
1/2019	Influenza epidemics observed in primary care from 1984 to 2017 in France: A decrease in epidemic size over time.
1/2018	Exploring the effect of previous inactivated influenza vaccination on seasonal influenza vaccine effectiveness against medically attended influenza: Results of the European I-MOVE multicentre test-negative case-control study, 2011/2012-2016/2017.
10/2017	Early estimates of 2016/17 seasonal influenza vaccine effectiveness in primary care in France.
1/2015	Early estimates of 2014/15 seasonal influenza vaccine effectiveness in preventing influenza-like illness in general practice using the screening method in France.
8/2014	Influenza vaccine effectiveness: best practice and current limitations of the screening method and their implications for the clinic.
4/2014	Genetic drift of influenza A(H3N2) viruses during two consecutive seasons in 2011-2013 in Corsica, France.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alessandra Falchi Research Topics

Disease

18	Human Influenza (Influenza) 01/2024 - 01/2011
11	Infections 03/2024 - 05/2011
6	COVID-19 03/2024 - 01/2021
1	Chronic Disease (Chronic Diseases) 03/2024
1	Smallpox (Variola) 12/2022
1	Severe Acute Respiratory Syndrome 01/2022
1	Zoonoses 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2017
1	Tetanus 01/2015
1	Urethritis 05/2011
1	beta-Thalassemia (Cooley's Anemia) 01/2005

Drug/Important Bio-Agent (IBA)

14	VaccinesIBA 03/2024 - 01/2011
7	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2024 - 11/2013
5	Immunoglobulin G (IgG)IBA 01/2024 - 01/2020
4	COVID-19 VaccinesIBA 03/2024 - 01/2021
3	Neutralizing AntibodiesIBA 01/2024 - 01/2022
3	AntibodiesIBA 01/2022 - 01/2020
2	BNT162 VaccineIBA 03/2024 - 01/2022
2	Hemagglutinins (Hemagglutinin)IBA 01/2024 - 01/2011
2	CI 22IBA 01/2023 - 10/2017
2	Viral RNAIBA 01/2019 - 12/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 05/2011
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 03/2024
1	N-(2-cyanoethylene)urea (BA 1)IBA 03/2024
1	Anti-Idiotypic AntibodiesIBA 01/2024
1	EnzymesIBA 01/2020
1	Drinking WaterIBA 01/2020
1	1- (3,4- dihydroxyphenyl)- 2- (3- (4- carbamylphenyl)- 1- methylpropylamino)ethanolIBA 01/2019
1	Antiviral Agents (Antivirals)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	AD 20 (AD-20)IBA 01/2018
1	cloricromen (AD 6)IBA 01/2018
1	AntipyreticsIBA 11/2017
1	cyclo(Arg-Pro) (CI 4)IBA 01/2015
1	SolutionsIBA 01/2015
1	2,5-dichloro-4-bromophenol (B 2)IBA 06/2012
1	DNA (Deoxyribonucleic Acid)IBA 08/2011
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 05/2011
1	Ciprofloxacin (Cipro)FDA LinkGeneric 05/2011
1	Azithromycin (Zithromax)FDA LinkGeneric 05/2011
1	beta-Globins (beta Globin)IBA 01/2005
1	Nonsense Codon (Nonsense Mutation)IBA 01/2005

Therapy/Procedure

1	Ambulatory Care (Outpatient Care) 01/2021
1	Home Nursing (Nursing, Home) 01/2017